Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumors.
Saved in:
| Title: | Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumors. |
|---|---|
| Authors: | Shemesh CS; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA. shemesh.colby@gene.com., Wang Y; Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, China., An A; Safety Science, F. Hoffmann-La Roche Ltd, Beijing, China., Ding H; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA., Chan P; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA., Liu Q; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA., Chen YW; Bioanalytical Science, Genentech Inc., South San Francisco, CA, USA., Wu B; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA., Wu Q; Product Development Oncology, F. Hoffmann-La Roche Ltd, Shanghai, China., Wang X; Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, China. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Jul; Vol. 94 (1), pp. 45-55. Date of Electronic Publication: 2024 Mar 07. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38451273 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shemesh+CS%22">Shemesh CS</searchLink>; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA. shemesh.colby@gene.com.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22An+A%22">An A</searchLink>; Safety Science, F. Hoffmann-La Roche Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Ding+H%22">Ding H</searchLink>; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chan+P%22">Chan P</searchLink>; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+Q%22">Liu Q</searchLink>; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+YW%22">Chen YW</searchLink>; Bioanalytical Science, Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wu+B%22">Wu B</searchLink>; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wu+Q%22">Wu Q</searchLink>; Product Development Oncology, F. Hoffmann-La Roche Ltd, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2024 Jul; Vol. 94 (1), pp. 45-55. <i>Date of Electronic Publication: </i>2024 Mar 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38451273 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00280-024-04650-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 45 Titles: – TitleFull: Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shemesh CS – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: An A – PersonEntity: Name: NameFull: Ding H – PersonEntity: Name: NameFull: Chan P – PersonEntity: Name: NameFull: Liu Q – PersonEntity: Name: NameFull: Chen YW – PersonEntity: Name: NameFull: Wu B – PersonEntity: Name: NameFull: Wu Q – PersonEntity: Name: NameFull: Wang X IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2024 Jul Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1432-0843 Numbering: – Type: volume Value: 94 – Type: issue Value: 1 Titles: – TitleFull: Cancer chemotherapy and pharmacology Type: main |
| ResultId | 1 |
